Quantitation of RhoA activation: differential binding to downstream effectors

Area of Science:

• Cellular biology
• Molecular signaling
• GTPase biology

Background:

• The small GTPase RhoA regulates crucial cellular functions via downstream effectors.
• RhoA effectors typically possess a Rho-binding domain (RBD) that interacts with active RhoA.
• GST-RBD fusion proteins, particularly Rhotekin RBD, are standard tools for measuring RhoA activation.

Purpose of the Study:

• To investigate whether all active RhoA forms interact with the Rhotekin RBD.
• To explore the specificity of RhoA interactions with different effectors.
• To determine if RhoA activation is effector-specific.

Main Methods:

• GST pulldown assays to assess RhoA-RBD interactions.
• BRET (Bioluminescence Resonance Energy Transfer) assay to study RhoA binding in a cellular context.
• Utilizing constitutively active RhoA mutants (e.g., RhoA-G14V) and RhoA activation by cellular stimuli.

Main Results:

• A constitutively active RhoA-G14V mutant failed to bind the Rhotekin RBD, despite interacting with ROCK2 and mDIA1 RBDs.
• Active RhoA induced by various stimuli exhibited differential binding preferences for its effectors.
• The study identified limitations in using Rhotekin RBD as the sole indicator of RhoA activation.

Conclusions:

• RhoA activation is effector-specific, leading to differential regulation of downstream pathways.
• Rhotekin RBD interaction does not encompass all forms of active RhoA.
• RhoA activation status should be assessed considering its interaction with diverse effectors, not just Rhotekin.